Touyun Biotech Group (1332.HK) Earnings Analysis
Touyun Biotech Group (1332.HK) has no confirmed upcoming earnings date. Trailing P/E 33.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1332.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 1332.HK. This page updates as the calendar is published.
1332.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-23 | -0.0171 HKD | n/a | n/a | n/a |
1332.HK valuation and analyst view
| Trailing P/E | 33.72 |
|---|---|
| Trailing EPS | 0.00482 HKD |
| Price / book | -15.79 |
| Dividend yield | 0.00% |
| Market cap | 0.42B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Touyun Biotech Group (1332.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 1332.HK. This page updates as the calendar is published.
Did 1332.HK beat earnings last quarter?
Consensus estimate data was not available for 1332.HK's 2024-08-23 report.
What is 1332.HK's current P/E ratio and EPS?
1332.HK trades at a trailing P/E of 33.72 on trailing EPS of 0.004816791206676482 HKD.
What do analysts rate 1332.HK?
1332.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.